MedTrace Logo

Real-world Data Analysis of REN Treatment in Migraine Patients

NCT04992897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12151

Last updated 2024-11-22

No results posted yet for this study

Summary

Data analysis concerning four sets of metrics: A. Per-treatment patterns of REN use as a standalone treatment vs. in combination with medications. B. Per-user Intra-individual consistency of efficacy across multiple treatments (consistency defined as a response to treatment in at least 50% of treatments). C. Distribution of treatment intensity among users (the electroceutical equivalent to treatment dose). D. Prevalence and severity of adverse events.

Conditions

Interventions

DEVICE

Remote Electrical Neuromodulation (REN)

Acute migraine treament

Sponsors & Collaborators

  • Georgetown University

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Theranica

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2021-08-07
Completion
2021-08-10
FDA Device
Yes

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04992897 on ClinicalTrials.gov